Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma

Affiliations

• ¹ Department of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.
• ² Department of Hematology and Oncology, University of California, Irvine, CA.
• ³ Department of Medicine, Massachusetts General Hospital, Boston, MA.
• ⁴ Alfred Hospital and Central Clinical School, Monash University, Melbourne, VIC, Australia.
• ⁵ Department of Medicine, Albert Einstein College of Medicine, New York, NY.
• ⁶ Department of Hematology, Yale University Cancer Center, Greenwich, CT.
• ⁷ Experimental Transplantation & Immunotherapy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
• ⁸ Blood and Marrow Transplant/Acute Leukemia Program, Intermountain Medical Group, Salt Lake City, UT.
• ⁹ Division of Hematology and Oncology, University of Virginia Cancer Center, Charlottesville, VA.